Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omegaven in SICU patients
NCT00172198Phase 4Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Mar 2005
- Modality
- Lipid-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of eicosapentaenoic acid + docosahexaenoic acid in critical illness, sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
eicosapentaenoic acid + docosahexaenoic acid
03
Conditions
critical illness
Beyond the preview
Go deeper on NCT00172198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00172198.